Giovanella, L.; Tuncel, M.; Campennì, A.; Ruggeri, R.M.; Huellner, M.; Petranović Ovčariček, P.
Endocrine Adverse Events Induced by Cancer Treatments: The Role of 18F-Fluorodeoxyglucose Positron Emission Tomography. Cancers 2025, 17, 2651.
https://doi.org/10.3390/cancers17162651
AMA Style
Giovanella L, Tuncel M, Campennì A, Ruggeri RM, Huellner M, Petranović Ovčariček P.
Endocrine Adverse Events Induced by Cancer Treatments: The Role of 18F-Fluorodeoxyglucose Positron Emission Tomography. Cancers. 2025; 17(16):2651.
https://doi.org/10.3390/cancers17162651
Chicago/Turabian Style
Giovanella, Luca, Murat Tuncel, Alfredo Campennì, Rosaria Maddalena Ruggeri, Martin Huellner, and Petra Petranović Ovčariček.
2025. "Endocrine Adverse Events Induced by Cancer Treatments: The Role of 18F-Fluorodeoxyglucose Positron Emission Tomography" Cancers 17, no. 16: 2651.
https://doi.org/10.3390/cancers17162651
APA Style
Giovanella, L., Tuncel, M., Campennì, A., Ruggeri, R. M., Huellner, M., & Petranović Ovčariček, P.
(2025). Endocrine Adverse Events Induced by Cancer Treatments: The Role of 18F-Fluorodeoxyglucose Positron Emission Tomography. Cancers, 17(16), 2651.
https://doi.org/10.3390/cancers17162651
